Capricor Therapeutics
CAPR
#6230
Rank
โ‚น54.91 B
Marketcap
โ‚น1,554
Share price
-9.85%
Change (1 day)
557.20%
Change (1 year)

Revenue for Capricor Therapeutics (CAPR)

Revenue in 2024 (TTM): โ‚น2.26 Billion

According to Capricor Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น2.28 Billion. In 2023 the company made a revenue of โ‚น2.09 Billion an increase over the revenue in the year 2022 that were of โ‚น0.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Capricor Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น2.26 B7.87%
2023 โ‚น2.09 B892.75%
2022 โ‚น0.21 B1058.29%
2021 โ‚น18.22 M-19.66%
2020 โ‚น22.68 M-68.34%
2019 โ‚น71.66 M-38.67%
2018 โ‚น0.11 B-16.45%
2017 โ‚น0.13 B-35.48%
2016 โ‚น0.21 B-13.61%
2015 โ‚น0.25 B-4.98%
2014 โ‚น0.26 B
2013 N/A-100%
2012 โ‚น10.7 M-85.06%
2011 โ‚น71.65 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น0.26 B-88.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.37 B-83.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.276 T 318,754.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น178.14 B 7,705.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.69 B-69.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น13.61 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA